We answer the “what” and the “why” of drug coverage, reimbursement and overall market access.
MMIT is regarded as a trusted go-to-market partner that identifies barriers to patient access and helps coordinate major stakeholders to move therapies from pipeline to patient—answering the “what” of how payers cover therapies and the “why” behind those decisions. MMIT’s product portfolio has been built by listening to our clients, and with expert teams of pharmacists, clinicians, data specialists and market researchers who provide foresight, clarity and confidence. This is the hallmark of who we are and who we will always be.
Our Past
More than two decades ago, MMIT (Managed Markets Insight & Technology, LLC) began as a division of Medi-Media, an agency supporting pharmaceutical clients in key areas of commercialization. Since then, MMIT acquired Atlantic Information Services (AIS), the creator of the Directory of Health Plans and leading healthcare publications; Zitter Health Insights, a provider of market access insights and solutions for specialty drugs; and RJ Health, the market leader in pricing and coding solutions for infusion drugs covered under the medical benefit.
In 2022, MMIT joined forces with other market-leading pharmaceutical solutions providers—Citeline, Evaluate, Panalgo and The Dedham Group—to launch our parent company, Norstella.
Our Future
Today, MMIT’s solutions are powered by NorstellaLinQ—the industry’s most complete and connected data asset—which consists of MMIT’s proprietary payer, formulary and provider data alongside critical real-world patient data such as open and closed claims, lab data, and EMR/EHR data. NorstellaLinQ also incorporates proprietary data from across the Norstella brands, from forecasting data to clinical trial data to regulatory data and more.
When MMIT clients choose NorstellaLinQ, they gain access to must-have answers for critical strategic and commercial decision-making along the entire drug development journey.
We answer the “what” and the “why” related to drug coverage, reimbursement and patient access.
MMIT brings transparency to pharmacy and medical benefit information, partnering with pharmacy benefit managers (PBMs), payers and pharmaceutical manufacturers from pharmacy and therapeutics (P&T) to point of care. We analyze market access trends and market readiness challenges while providing brand and market access solutions to navigate the rapidly changing healthcare market.
We leverage advanced technologies, research and industry experts to make sense of how and why specific pharmaceutical drugs are covered. Physicians and pharmacies use our data and applications to understand what drugs are available to patients and how they are covered by health plans. Pharmaceutical manufacturers trust our data to understand how their drug and competitive drugs are covered, which helps forecast performance and fine-tune strategy.
MMIT has been 100% focused on market access for decades. We combine deep domain expertise around drug coverage with innovative technology and trusted data to answer key business questions related to commercialization and market access. MMIT data is trusted by U.S. physicians and sourced through a combination of direct partnerships with payers/PBMs and a technology infrastructure, powered by smart business logic, artificial intelligence and human validation.
Acquired in early 2019, Zitter Insights is a division of MMIT that brings market research and helps address the “why” of market access. Our Zitter Insights panel represents top health plans, PBMs and IDNs to provide meaningful insights to our clients.
AIS Health, acquired in 2016, is a publishing and information company that has served the health care industry for more than 30 years. Our mission is to provide our readers with an actionable understanding of the business of health care and pharmaceuticals.